Financial Instruments and Fair Value Measurements - Additional Information (Details) - USD ($)		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2020	Dec. 31, 2019
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Financial liabilities measured at fair value on a recurring basis			$ 0
Cash and cash equivalents		$ 1,021,000,000	723,000,000
Derivative instruments not designated as hedging instruments, description of terms		We generally use forward contracts to reduce the effects of foreign currency exchange rate fluctuations on our cash flows for the Euro versus the U.S. Dollar. For the periods ended December 31, 2022, 2021 and 2020, respectively, our forward contracts have not been designated as hedges and generally had maturities of less than 90 days.
Foreign currency exchange contracts maturity period, maximum		90 days
Earnings (losses) from equity method investment, net		$ (2,000,000)	(3,000,000)	$ (3,000,000)
Maturity of term deposits		90 days or less at the date of purchase, in each case, with
Short-term marketable securities outstanding		$ 0	0
Long-term marketable securities outstanding		0	0
Derivative Gain Loss On Derivative Net		$ 4,000,000	$ 2,000,000	$ 1,000,000
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]		Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Deferred income liability	[1]	$ 28,000,000	$ 31,000,000
Equity securities without readily determinable fair value		$ 2,000,000	2,000,000
Other Long-Term Assets
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Redeemable noncontrolling interest, settlement amount					$ 20,000,000
Percentage of notes receivable due in 5 years		50.00%
Percentage of notes receivable due in 10 years		50.00%
Allowance for credit loss under ASC 326			5,000,000	$ 3,000,000
Net of accumulated allowance for credit losses, Carrying value		$ 9,000,000	9,000,000
Chelsea Investment Holding Company PTE, Ltd
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Equity method investment, ownership percentage		40.00%
Equity method investments						$ 41,000,000
Deferred income liability		$ 31,000,000				$ 39,000,000
Deferred gain recognition period		15 years
Impairment loss on equity method investments		$ 0	0	$ 0
Chelsea Investment Holding Company PTE, Ltd | Non-Marketable Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Equity method investments		32,000,000	34,000,000
Chelsea Investment Holding Company PTE, Ltd | Accrued Expenses and Other Current Liabilities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Deferred income liability		3,000,000
Chelsea Investment Holding Company PTE, Ltd | Other Long-term Liabilities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Deferred income liability		28,000,000
Level 3 Unobservable Inputs
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Financial assets measured at fair value on a recurring basis		0	0
Financial liabilities measured at fair value on a recurring basis		0	$ 0
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Cash and cash equivalents, consisted of bank deposits	[2]	$ 200,000,000

[1] Amount relates to long-term portion of a deferred income liability recorded as a result of an equity method investment made in the fourth quarter of 2019. Refer to “Note 4: Financial Instruments and Fair Value Measurements” for additional information

[2] We did not have any unrealized gains and losses related to our cash equivalents.